Antitumor activity of lentivirus-mediated interleukin -12 gene modified dendritic cells in human lung cancer in vitro

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 2, 2014, Pages 611-616

  Ahmed Ali, Hassan Abdellah ^a   Di, Jun ^a,b   Mei, Wu ^a   Zhang, Yu Cheng ^a   Li, Yi ^a   Du, Zhen Wu ^a   Zhang, Gui Zhen ^a  

^a JILIN UNIVERSITY   (China)

^b Jilin Province   (China)

Author keywords

Dendritic cell; Interleukin 12; Lentivirus vector; Lung cancer cells; T lymphocytes

Indexed keywords

CANCER VACCINE; INTERLEUKIN 12; MESSENGER RNA;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG EFFECT; FLOW CYTOMETRY; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; IN VITRO STUDY; LENTIVIRINAE; LUNG TUMOR; METABOLISM; MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CANCER VACCINES; CELL PROLIFERATION; DENDRITIC CELLS; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-12; LENTIVIRUS; LEUKOCYTES, MONONUCLEAR; LUNG NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 84894662406     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.2.611     Document Type: Article

References (30)

1. Coca S, Enrech S, Moreno Garcia V, et al (2005). Evaluation of the antitumor activity of interleukin-12 in an experimental murine model of colorectal cancer induced by 1, 2 dimethyl-hydrazine (DMH). Rev Esp Enferm Dig, 97, 619-28.
2. Cranmer LD, Trevor KT Hersh EM (2004). Clinical applications of dendritic cell vaccination in the treatment of cancer. Cancer Immunol Immunother, 53, 275-306.
3. Dullaers M, Van Meirvenne S, Heirman C, et al (2006). Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors. Gene Ther, 13, 630-40.
4. Fuss IJ, Kanof ME, Smith PD Zola H (2009). Isolation of whole mononuclear cells from peripheral blood and cord blood. Curr Protoc Immunol Chapter, 7, Unit7 1.
5. Garg NK, Dwivedi P, Prabha P Tyagi RK (2013). RNA pulsed dendritic cells: an approach for cancer immunotherapy. Vaccine, 31, 1141-56.
6. Gately MK, Desai BB, Wolitzky AG, et al (1991). Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol, 147, 874-82.
7. Gherardi MM, Ramirez JC Esteban M (2000). Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediated by nitric oxide. J Virol, 74, 6278-86.
8. Guermonprez P, Valladeau J, Zitvogel L, Thery C Amigorena S (2002). Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol, 20, 621-67.
9. Han B, Zhong H, Fan X, et al (2006). [A primary study of immunotherapy with carcinoembryonic antigen peptide-pulsed, autologous human cultured dendritic cells in patients with advanced non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi, 9, 340-4.
10. Hansen M, Hjorto GM, Donia M, et al (2013). Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy. Vaccine, 31, 639-46.
11. Hwang EC, Lim MS, Im CM, et al (2013). Generation of potent cytotoxic T lymphocytes against castration-resistant prostate cancer cells by dendritic cells loaded with dying allogeneic prostate cancer cells. Scand J Immunol, 77, 117-24.
12. Janeway CA, Jr. Medzhitov R (2002). Innate immune recognition. Annu Rev Immunol, 20, 197-216.
13. Kaech SM Ahmed R (2003). Immunology. CD8 T cells remember with a little help. Science, 300, 263-5.
14. Kikuchi T, Akasaki Y, Irie M, et al (2001). Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells. Cancer Immunol Immunother, 50, 337-44.
15. Koutsokera A, Kiagia M, Saif MW, Souliotis K Syrigos KN (2013). Nutrition Habits, Physical Activity, and Lung Cancer: An Authoritative Review. Clin Lung Cancer, 14, 342-50.
16. Lesterhuis WJ, de Vries IJ, Adema GJ Punt CJ (2004). Dendritic cell-based vaccines in cancer immunotherapy: an update on clinical and immunological results. Ann Oncol, 15 Suppl 4, iv145-51.
17. Li R, Zheng X, Popov I, et al (2012). Gene silencing of IL-12 in dendritic cells inhibits autoimmune arthritis. J Transl Med, 10, 19.
18. Marten A, Renoth S, Heinicke T, et al (2003). Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma. Hum Gene Ther, 14, 483-94.
19. Mehrotra PT, Wu D, Crim JA, Mostowski HS Siegel JP (1993). Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes. J Immunol, 151, 2444-52.
20. Nouri-Shirazi M, Banchereau J, Fay J Palucka K (2000). Dendritic cell based tumor vaccines. Immunol Lett, 74, 5-10.
21. Perroud MW, Jr., Honma HN, Barbeiro AS, et al (2011). Mature autologous dendritic cell vaccines in advanced non-small cell lung cancer: a phase I pilot study. J Exp Clin Cancer Res, 30, 65.
22. Picanco-Castro V, de Sousa Russo-Carbolante EM Tadeu Covas D (2012). Advances in lentiviral vectors: a patent review. Recent Pat DNA Gene Seq, 6, 82-90.
23. Portielje JE, Gratama JW, van Ojik HH, Stoter G Kruit WH (2003). IL-12: a promising adjuvant for cancer vaccination. Cancer Immunol Immunother, 52, 133-44.
24. Ragde H, Cavanagh WA Tjoa BA (2004). Dendritic cell based vaccines: progress in immunotherapy studies for prostate cancer. J Urol, 172, 2532-8.
25. Schuler G Romani N (1997). Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. Adv Exp Med Biol, 417, 7-13.
26. Seggewiss R Dunbar CE (2005). A new direction for gene therapy: intrathymic T cell-specific lentiviral gene transfer. J Clin Invest, 115, 2064-7.
27. Song Z, Guo C, Li Y, et al (2012). Enhanced antitumor effects of a dendritic cell vaccine transfected with gastric cancer cell total RNA carrying the 4-1BBL gene in vitro. Exp Ther Med, 3, 319-23.
28. Tamandani DM, Shekari M Suri V (2009). Interleukin-12 gene polymorphism and cervical cancer risk. Am J Clin Oncol, 32, 524-528.
29. Vannucci L, Lai M, Chiuppesi F, Ceccherini-Nelli L Pistello M (2013). Viral vectors: a look back and ahead on gene transfer technology. New Microbiol, 36, 1-22.
30. Wang J, Zou ZH, Xia HL, et al (2012). Strengths and weaknesses of immunotherapy for advanced non-small-cell lung cancer: a meta-analysis of 12 randomized controlled trials. PLoS One, 7, e32695.